Impact of COVID-19 on Tuberculosis Prevention and Treatment in Canada: A Multicenter Analysis of 10 833 Patients | Zendy

Coralie Geric | Zendy; Mariane Saroufim | Zendy; David Landsman | Zendy; Jonathan Richard | Zendy; Andrea Benedetti | Zendy; Jane Batt | Zendy; Sarah K. Brode | Zendy; Faiz Ahmad Khan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of COVID-19 on Tuberculosis Prevention and Treatment in Canada: A Multicenter Analysis of 10 833 Patients

Author(s) -

Coralie Geric,

Mariane Saroufim,

David Landsman,

Jonathan Richard,

Andrea Benedetti,

Jane Batt,

Sarah K. Brode,

Faiz Ahmad Khan

Publication year - 2021

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiab608

Subject(s) - tuberculosis , medicine , pandemic , latent tuberculosis , active tuberculosis , covid-19 , public health , virology , mycobacterium tuberculosis , outbreak , pathology , disease , infectious disease (medical specialty)

We assessed the COVID-19 pandemic’s impact on treatment of latent tuberculosis, and of active tuberculosis, at 3 centers in Montreal and Toronto, using data from 10 833 patients (8685 with latent tuberculosis infection, 2148 with active tuberculosis). Observation periods prior to declarations of COVID-19 public health emergencies ranged from 219 to 744 weeks, and after declarations, from 28 to 33 weeks. In the latter period, reductions in latent tuberculosis infection treatment initiation rates ranged from 30% to 66%. At 2 centers, active tuberculosis treatment rates fell by 16% and 29%. In Canada, cornerstone measures for tuberculosis elimination weakened during the COVID-19 pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research